Easton Pharmaceuticals Inc EAPH:Over The Counter Market

Last Price$0.0015Over The Counter Market Previous Close - Last Trade as of 3:57PM ET 6/05/20

Today's Change0(0.00%)
Bid (Size)$0.0023 (250,000)
Ask (Size)$0.0197 (45,000)
Day Low / HighN/A - N/A
Volume538.8 K
 

View Medical Specialties IndustryPeer Comparison as of 06/05/2020

 

Easton Pharmaceuticals Inc ( OTC )

Price: $0.0015
Change: +0.0004 (36.36%)
Volume: 538.8 K
3:57PM ET 6/05/2020
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 
 

N/A ( N/A )

Price: N/A
Change: N/A N/A
Volume: N/A
N/A
 

Read more news Recent News

No news stories available at this time.

View all Commentary and Analysis

No news stories available at this time.

Company Profile

Business DescriptionEaston Pharmaceuticals, Inc. engages in the design, development, and marketing of drugs, therapeutic, and cosmetic healthcare products. It owns wound-healing drug and topically delivered drugs to treat cancer and other therapeutic products. The company was founded by John K. Easton on February 4, 1997 and is headquartered in Toronto, Canada. View company web site for more details
Address61 Elm Street
Toronto, Ontario M5G 1H2
Phone+1.647.362.5700
Number of EmployeesN/A
President, Chief Executive Officer & DirectorEvan Karras
Chief Operating Officer & DirectorVince Demasi
Chief Medical OfficerJose Tiran Saucedo
SecretaryJohn Guerra

Company Highlights

Price Open$0.0013
Previous Close$0.0011
52 Week Range$0.00 - 0.0078
Market Capitalization$2.0 M
Shares Outstanding1.3 B
SectorHealth Technology
IndustryMedical Specialties
Next Earnings AnnouncementN/A

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.0001
Beta vs. S&P 500N/A
Revenue$378.6 K
Net Profit Margin-13.79%
Return on Equity-2.82%